Anhui Huaheng Valuation
| 688639 Stock | 32.61 0.34 1.03% |
At this time, the firm appears to be overvalued. Anhui Huaheng Biotec shows a prevailing Real Value of USD30.29 per share. The current price of the firm is USD32.61. Our model approximates the value of Anhui Huaheng Biotec from analyzing the firm fundamentals such as profit margin of 0.14 %, and Return On Equity of 0.17 as well as examining its technical indicators and probability of bankruptcy.
Price Book 4.3815 | Enterprise Value 9.7 B | Enterprise Value Ebitda 27.0564 | Price Sales 3.8537 | Trailing PE 25.0846 |
Overvalued
Today
Please note that Anhui Huaheng's price fluctuation is not too volatile at this time. Calculation of the real value of Anhui Huaheng Biotec is based on 3 months time horizon. Increasing Anhui Huaheng's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Anhui Huaheng is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Anhui Stock. However, Anhui Huaheng's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 32.61 | Real 30.29 | Hype 32.43 |
The real value of Anhui Stock, also known as its intrinsic value, is the underlying worth of Anhui Huaheng Biotec Company, which is reflected in its stock price. It is based on Anhui Huaheng's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Anhui Huaheng's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Anhui Huaheng Biotechnology helps investors to forecast how Anhui stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Anhui Huaheng more accurately as focusing exclusively on Anhui Huaheng's fundamentals will not take into account other important factors: Anhui Huaheng Cash |
|
Anhui Huaheng Total Value Analysis
Anhui Huaheng Biotechnology is presently forecasted to have takeover price of 9.74 B with market capitalization of 8.14 B, debt of 941.72 M, and cash on hands of . Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Anhui Huaheng fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
9.74 B | 8.14 B | 941.72 M |
Anhui Huaheng Investor Information
About 38.0% of the company shares are owned by insiders or employees . The book value of Anhui Huaheng was presently reported as 8.02. The company last dividend was issued on the 22nd of July 2024. Anhui Huaheng Biotec had 1.45:1 split on the 22nd of July 2024. Anhui Huaheng Biotechnology is not in a good financial situation at this time. It has a very high odds of going through financial crisis in January.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Total Cash From Operating Activities | 230 M | 301.4 M |
|
| |||||
| Operating Income | 290.9 M | 514.8 M |
|
|
Anhui Huaheng Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Anhui Huaheng has an asset utilization ratio of 48.82 percent. This suggests that the Company is making USD0.49 for each dollar of assets. An increasing asset utilization means that Anhui Huaheng Biotechnology is more efficient with each dollar of assets it utilizes for everyday operations.Anhui Huaheng Ownership Allocation
Anhui Huaheng holds a total of 249.72 Million outstanding shares. Anhui Huaheng Biotechnology retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Anhui Huaheng Profitability Analysis
The company reported the revenue of 1.94 B. Net Income was 449.06 M with profit before overhead, payroll, taxes, and interest of 343.67 M.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Anhui Huaheng's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Anhui Huaheng and how it compares across the competition.
About Anhui Huaheng Valuation
The stock valuation mechanism determines Anhui Huaheng's current worth on a weekly basis. Our valuation model uses a comparative analysis of Anhui Huaheng. We calculate exposure to Anhui Huaheng's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Anhui Huaheng's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 785.3 M | 455.1 M |
Anhui Huaheng Quarterly Retained Earnings |
|
Complementary Tools for Anhui Stock analysis
When running Anhui Huaheng's price analysis, check to measure Anhui Huaheng's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anhui Huaheng is operating at the current time. Most of Anhui Huaheng's value examination focuses on studying past and present price action to predict the probability of Anhui Huaheng's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anhui Huaheng's price. Additionally, you may evaluate how the addition of Anhui Huaheng to your portfolios can decrease your overall portfolio volatility.
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |